Skip to main content
Top
Published in: European Radiology 3/2012

01-03-2012 | Computed Tomography

The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer

Authors: Xiang Sheng Li, Hong Xia Fan, Hong Xian Zhu, Yun Long Song, Chun Wu Zhou

Published in: European Radiology | Issue 3/2012

Login to get access

Abstract

Objective

To determine the value of the perfusion parameters in predicting short-term tumour response to synchronous radiochemotherapy for cervical squamous carcinoma.

Methods

Ninety-three patients with cervical squamous carcinoma later than stage IIB were included in this study. Perfusion CT was performed for all these patients who subsequently received the same synchronous radiochemotherapy. The patients were divided into responders and non-responders according to short-term response to treatment. Baseline perfusion parameters of the two groups were compared. The perfusion parameters that might affect treatment effect were analysed by using a multivariate multi-regression analysis.

Results

The responders group had higher baseline permeability-surface area product (PS) and blood volume (BV) values than the non-responders group (P < 0.05). There was no statistical difference in baseline mean transit time (MTT) and blood flow (BF) value between the two groups (P >0.05). At multivariate multi-regression analysis, BV, PS and tumour size were significant factors in the prediction of treatment effect. Small tumours usually had high PS and BV values, and thus had a good treatment response.

Conclusion

Perfusion CT can provide some helpful information for the prediction of the short-term effect. Synchronous radiochemotherapy may be more effective in cervical squamous carcinoma with higher baseline PS and BV.

Key Points

Perfusion CT can reflect tumour vascular physiology in cervical squamous carcinoma.
Perfusion CT helps predict the short-term effect before treatment
Synchronous radiochemotherapy may be more effective in patients with higher baseline BV and PS.
Literature
1.
go back to reference Nam H, Park W, Huh SJ et al (2007) The prognostic significance of tumour regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 107:320–325PubMedCrossRef Nam H, Park W, Huh SJ et al (2007) The prognostic significance of tumour regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 107:320–325PubMedCrossRef
2.
go back to reference Wang J, Wu N, Cham MD et al (2009) Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 193:1090–1096PubMedCrossRef Wang J, Wu N, Cham MD et al (2009) Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 193:1090–1096PubMedCrossRef
3.
go back to reference Bisdas S, Rumboldt Z, Wagenblast J et al (2009) Response and progression-free survival in oropharynx cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements. AJNR Am J Neuroradiol 30:793–799PubMedCrossRef Bisdas S, Rumboldt Z, Wagenblast J et al (2009) Response and progression-free survival in oropharynx cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements. AJNR Am J Neuroradiol 30:793–799PubMedCrossRef
4.
go back to reference Chen Y, Zhang J, Dai J et al (2010) Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 35:622–628PubMedCrossRef Chen Y, Zhang J, Dai J et al (2010) Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 35:622–628PubMedCrossRef
5.
go back to reference Ash L, Teknos TN, Gandhi D et al (2009) Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 251:422–428PubMedCrossRef Ash L, Teknos TN, Gandhi D et al (2009) Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 251:422–428PubMedCrossRef
6.
go back to reference Surlan-Popovic K, Bisdas S, Rumboldt Z et al (2010) Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 31:570–575PubMedCrossRef Surlan-Popovic K, Bisdas S, Rumboldt Z et al (2010) Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 31:570–575PubMedCrossRef
7.
go back to reference Zhang Q, Yuan ZG, Wang DQ et al (2010) Perfusion CT findings in liver of patients with tumor during chemotherapy. World J Gastroenterol 16:3202–3205PubMedCrossRef Zhang Q, Yuan ZG, Wang DQ et al (2010) Perfusion CT findings in liver of patients with tumor during chemotherapy. World J Gastroenterol 16:3202–3205PubMedCrossRef
8.
go back to reference Lind JS, Meijerink MR, Dingemans AM et al (2010) Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? Eur Radiol 20:2890–2898PubMedCrossRef Lind JS, Meijerink MR, Dingemans AM et al (2010) Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? Eur Radiol 20:2890–2898PubMedCrossRef
9.
go back to reference d’Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416PubMedCrossRef d’Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416PubMedCrossRef
10.
go back to reference Fournier LS, Oudard S, Thiam R et al (2010) Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology 256:511–518PubMedCrossRef Fournier LS, Oudard S, Thiam R et al (2010) Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology 256:511–518PubMedCrossRef
11.
go back to reference Hayano K, Shuto K, Koda K et al (2009) Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer. Dis Colon Rectum 52:1624–1629PubMedCrossRef Hayano K, Shuto K, Koda K et al (2009) Quantitative measurement of blood flow using perfusion CT for assessing clinicopathologic features and prognosis in patients with rectal cancer. Dis Colon Rectum 52:1624–1629PubMedCrossRef
12.
go back to reference Petralia G, Preda L, Giugliano G et al (2009) Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume. J Comput Assist Tomogr 33:552–559PubMedCrossRef Petralia G, Preda L, Giugliano G et al (2009) Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume. J Comput Assist Tomogr 33:552–559PubMedCrossRef
13.
go back to reference Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205–216PubMedCrossRef Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205–216PubMedCrossRef
14.
go back to reference Pandharipande PV, Krinsky GA, Rusinek H et al (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661–673PubMedCrossRef Pandharipande PV, Krinsky GA, Rusinek H et al (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661–673PubMedCrossRef
15.
go back to reference Park M, Dipl EK, Kim M et al (2009) Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 250:110–117PubMedCrossRef Park M, Dipl EK, Kim M et al (2009) Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 250:110–117PubMedCrossRef
16.
go back to reference Hegenscheid K, Behrendt N, Rosenberg C et al (2010) Assessing early vascular changes and treatment response after laser-induced thermotherapy of pulmonary metastases with perfusion CT: initial experience. AJR Am J Roentgenol 194:1116–1123PubMedCrossRef Hegenscheid K, Behrendt N, Rosenberg C et al (2010) Assessing early vascular changes and treatment response after laser-induced thermotherapy of pulmonary metastases with perfusion CT: initial experience. AJR Am J Roentgenol 194:1116–1123PubMedCrossRef
17.
go back to reference Haider MA, Milosevic M, Fyles A et al (2005) Assessment of tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 62:1100–1107PubMedCrossRef Haider MA, Milosevic M, Fyles A et al (2005) Assessment of tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys 62:1100–1107PubMedCrossRef
18.
go back to reference Tai JH, Tessier J, Ryan AJ et al (2010) Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the rude rat. Neoplasia 12:697–707PubMed Tai JH, Tessier J, Ryan AJ et al (2010) Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the rude rat. Neoplasia 12:697–707PubMed
19.
go back to reference Ng CS, Wang X, Faria SC et al (2010) Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon. AJR Am J Roentgenol 194:166–171PubMedCrossRef Ng CS, Wang X, Faria SC et al (2010) Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon. AJR Am J Roentgenol 194:166–171PubMedCrossRef
20.
go back to reference Goh V, Halllgan S, Gharypuray A et al (2008) Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology 247:726–732PubMedCrossRef Goh V, Halllgan S, Gharypuray A et al (2008) Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology 247:726–732PubMedCrossRef
21.
go back to reference Bellomi M, Petralia G, Sonzogni A et al (2007) CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 244:486–493PubMedCrossRef Bellomi M, Petralia G, Sonzogni A et al (2007) CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 244:486–493PubMedCrossRef
22.
go back to reference Makari Y, Yasuda T, Doki Y et al (2007) Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers. J Surg Oncol 96:220–229PubMedCrossRef Makari Y, Yasuda T, Doki Y et al (2007) Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers. J Surg Oncol 96:220–229PubMedCrossRef
23.
go back to reference Goh V, Halligan S, Daley F et al (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT—do tumor perfusion measurements reflect angiogenesis? Radiology 249:510–517PubMedCrossRef Goh V, Halligan S, Daley F et al (2008) Colorectal tumor vascularity: quantitative assessment with multidetector CT—do tumor perfusion measurements reflect angiogenesis? Radiology 249:510–517PubMedCrossRef
24.
go back to reference Hermans R, Van den Bogaert W (2009) Outcome prediction after surgery and chemoradiation of head-and-neck squamous cell carcinoma (HNSCC), using baseline perfusion computed tomography (CT) microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 74:1307PubMedCrossRef Hermans R, Van den Bogaert W (2009) Outcome prediction after surgery and chemoradiation of head-and-neck squamous cell carcinoma (HNSCC), using baseline perfusion computed tomography (CT) microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 74:1307PubMedCrossRef
25.
go back to reference Goh V, Halligan S, Hugill JA et al (2005) Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr 29:59–63PubMedCrossRef Goh V, Halligan S, Hugill JA et al (2005) Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr 29:59–63PubMedCrossRef
26.
go back to reference Yamashita Y, Baba T, Baba Y et al (2000) Dynamic contrast-enhancement MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 216:803–809PubMed Yamashita Y, Baba T, Baba Y et al (2000) Dynamic contrast-enhancement MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. Radiology 216:803–809PubMed
27.
go back to reference Šurlan-Popovič K, Bisdas S, Rumboldt Z et al (2010) Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 31:570–575PubMedCrossRef Šurlan-Popovič K, Bisdas S, Rumboldt Z et al (2010) Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 31:570–575PubMedCrossRef
28.
go back to reference Zhang H, Pan Z, Du L et al (2008) Advanced gastric cancer and perfusion imaging using a multidetector row computed tomography: correlation with prognostic determinants. Korean J Radiol 9:119–127PubMedCrossRef Zhang H, Pan Z, Du L et al (2008) Advanced gastric cancer and perfusion imaging using a multidetector row computed tomography: correlation with prognostic determinants. Korean J Radiol 9:119–127PubMedCrossRef
29.
go back to reference Meijerink MR, van Cruijsen H, Hoekman K et al (2007) The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol 17:1700–1713PubMedCrossRef Meijerink MR, van Cruijsen H, Hoekman K et al (2007) The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients. Eur Radiol 17:1700–1713PubMedCrossRef
30.
go back to reference Yang HF, Du Y, Ni JX et al (2010) Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 20:1424–1430PubMedCrossRef Yang HF, Du Y, Ni JX et al (2010) Perfusion computed tomography evaluation of angiogenesis in liver cancer. Eur Radiol 20:1424–1430PubMedCrossRef
31.
go back to reference Mayr NA, Yuh WT, Zheng J et al (1998) Prediction of tumour control in patients with cervical cancer: analysis of combined volume and dynamic enhancement patterns by MR imaging. AJR Am J Roentgenol 170:177–182PubMed Mayr NA, Yuh WT, Zheng J et al (1998) Prediction of tumour control in patients with cervical cancer: analysis of combined volume and dynamic enhancement patterns by MR imaging. AJR Am J Roentgenol 170:177–182PubMed
32.
go back to reference Lyng H, Vorren A, Sundfor K et al (2001) Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy. Int J Cancer 96:182–190PubMedCrossRef Lyng H, Vorren A, Sundfor K et al (2001) Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy. Int J Cancer 96:182–190PubMedCrossRef
33.
go back to reference Mayr NA, Yuh WT, Arnholt JC et al (2000) Pixel analysis of MR perfusion imaging in predicting radiation outcome in cervical cancer. J Magn Reson Imaging 12:1027–1033PubMedCrossRef Mayr NA, Yuh WT, Arnholt JC et al (2000) Pixel analysis of MR perfusion imaging in predicting radiation outcome in cervical cancer. J Magn Reson Imaging 12:1027–1033PubMedCrossRef
34.
go back to reference Bhosale P, Peungjesada S, Devine C et al (2010) Role of magnetic resonance imaging as a adjunct to clinical staging in cervical carcinoma. J Comput Assist Tomogr 34:855–864PubMedCrossRef Bhosale P, Peungjesada S, Devine C et al (2010) Role of magnetic resonance imaging as a adjunct to clinical staging in cervical carcinoma. J Comput Assist Tomogr 34:855–864PubMedCrossRef
35.
go back to reference Stenstedt K, Kellström AC, Fridsten S et al (2011) Impact of MRI in the management and staging of cancer of the uterine cervix. Acta Oncol 50:420–426PubMedCrossRef Stenstedt K, Kellström AC, Fridsten S et al (2011) Impact of MRI in the management and staging of cancer of the uterine cervix. Acta Oncol 50:420–426PubMedCrossRef
Metadata
Title
The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer
Authors
Xiang Sheng Li
Hong Xia Fan
Hong Xian Zhu
Yun Long Song
Chun Wu Zhou
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
European Radiology / Issue 3/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2280-6

Other articles of this Issue 3/2012

European Radiology 3/2012 Go to the issue